KIG
HZNP

Kowal Investment Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kowal Investment Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,922
Closed -$1.73M – 175
2023
Q3 		$1.73M Hold
14,922
– – 0.47% 28
2023
Q2 		$1.53M Hold
14,922
– – 0.41% 31
2023
Q1 		$1.63M Hold
14,922
– – 0.46% 30
2022
Q4 		$1.7M Sell
14,922
-1,285
-8% -$107K 0.51% 28
2022
Q3 		$1M Buy
16,207
+15
+0.1% +$1.05K 0.34% 37
2022
Q2 		$1.29M Buy
+16,192
New +$1.53M 0.42% 25

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kowal Investment Group's HZNP Position: Q4 2023 in Review

Kowal Investment Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 14,922 shares — an estimated $1.73M sold.

Kowal Investment Group first reported a position in HZNP in Q2 2022 and held it in 6 quarters. The position peaked at $1.73M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Kowal Investment Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Kowal Investment Group sold 14,922 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.73M.
  • Kowal Investment Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 6 quarters.
  • Kowal Investment Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.73M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Kowal Investment Group's 13F filing for Q4 2023, filed 22 Jan 2024.